Home
Chimeric Therapeutics Ltd
Encouraging data from 2nd dose cohort in CLTX CAR T trial
Business
Feb 8 2022
4 min read

Encouraging data from 2nd dose cohort in CLTX CAR T trial

news images

Chimeric Therapeutics Ltd has released a press release.

View Attachment